BRPI1012078A2 - construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênica - Google Patents
construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênicaInfo
- Publication number
- BRPI1012078A2 BRPI1012078A2 BRPI1012078A BRPI1012078A BRPI1012078A2 BR PI1012078 A2 BRPI1012078 A2 BR PI1012078A2 BR PI1012078 A BRPI1012078 A BR PI1012078A BR PI1012078 A BRPI1012078 A BR PI1012078A BR PI1012078 A2 BRPI1012078 A2 BR PI1012078A2
- Authority
- BR
- Brazil
- Prior art keywords
- immunogenic composition
- casb7439
- inducing
- treating
- human
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 2
- 230000028993 immune response Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18138009P | 2009-05-27 | 2009-05-27 | |
US22039609P | 2009-06-25 | 2009-06-25 | |
PCT/EP2010/057141 WO2010136443A1 (en) | 2009-05-27 | 2010-05-25 | Casb7439 constructs |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI1012078A2 true BRPI1012078A2 (pt) | 2019-09-24 |
Family
ID=42556967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1012078A BRPI1012078A2 (pt) | 2009-05-27 | 2010-05-25 | construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênica |
Country Status (19)
Country | Link |
---|---|
US (1) | US8916514B2 (pt) |
EP (1) | EP2435469A1 (pt) |
JP (1) | JP2012528106A (pt) |
KR (1) | KR20120014054A (pt) |
CN (1) | CN102459324B (pt) |
AU (1) | AU2010252012A1 (pt) |
BR (1) | BRPI1012078A2 (pt) |
CA (1) | CA2763486A1 (pt) |
CL (1) | CL2011002994A1 (pt) |
CO (1) | CO6400229A2 (pt) |
DO (1) | DOP2011000348A (pt) |
EA (1) | EA020617B1 (pt) |
IL (1) | IL216351A0 (pt) |
MA (1) | MA33409B1 (pt) |
MX (1) | MX2011012623A (pt) |
NZ (1) | NZ596501A (pt) |
PE (1) | PE20120400A1 (pt) |
SG (1) | SG176220A1 (pt) |
WO (1) | WO2010136443A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL151097A0 (en) | 2000-02-23 | 2003-04-10 | Smithkline Beecham Biolog | Tumour-specific animal proteins |
PT1889630E (pt) * | 2000-10-18 | 2012-02-29 | Glaxosmithkline Biolog Sa | Vacinas compreendendo o antigénio mage ligado a um fragmento da proteína d |
US20140171626A1 (en) * | 2012-12-19 | 2014-06-19 | Glaxosmithkline Llc | Protein purification |
GB201520568D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd | Peptides |
GB201520550D0 (en) | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
GB201520592D0 (en) * | 2015-11-23 | 2016-01-06 | Immunocore Ltd & Adaptimmune Ltd | Peptides |
AU2017331949A1 (en) * | 2016-09-21 | 2019-01-31 | Amal Therapeutics Sa | Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9300883A (es) | 1992-02-18 | 1994-08-31 | Smithkline Beecham Corp | Polipeptidos de vacuna. |
EP0679716A4 (en) | 1993-11-12 | 1999-06-09 | Kenichi Matsubara | GENE SIGNATURE. |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
CA2194761C (en) | 1994-07-15 | 2006-12-19 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6030945A (en) * | 1996-01-09 | 2000-02-29 | Genentech, Inc. | Apo-2 ligand |
KR100365986B1 (ko) | 1996-02-09 | 2003-02-20 | 스미스클라인 비이참 바이오로지칼즈 에스.에이. | 수두대상포진바이러스유전자63생성물에대한백신 |
JP4768121B2 (ja) | 1998-02-05 | 2011-09-07 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | Mageファミリーからの腫瘍関連抗原及びそれらをコードする核酸配列、融合タンパク質の及びワクチン接種のための組成物の調製のための使用 |
US6551795B1 (en) | 1998-02-18 | 2003-04-22 | Genome Therapeutics Corporation | Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics |
BR9908599A (pt) | 1998-03-09 | 2000-11-14 | Smithkline Beecham Biolog | Composições combinadas de vacina |
US6087168A (en) | 1999-01-20 | 2000-07-11 | Cedars Sinai Medical Center | Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells |
PT1165778E (pt) | 1999-03-11 | 2007-01-31 | Glaxosmithkline Biolog Sa | Utilizações de polinucleótidos e polipéptidos casb618 |
WO2001002828A2 (en) | 1999-07-07 | 2001-01-11 | Tularik Inc. | Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides |
AU3087801A (en) | 2000-02-04 | 2001-08-14 | Molecular Dynamics Inc | Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells |
US7811574B2 (en) * | 2000-02-23 | 2010-10-12 | Glaxosmithkline Biologicals S.A. | Tumour-specific animal proteins |
IL151097A0 (en) * | 2000-02-23 | 2003-04-10 | Smithkline Beecham Biolog | Tumour-specific animal proteins |
UA79735C2 (uk) * | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
US8039602B2 (en) | 2000-10-31 | 2011-10-18 | Ryogen Llc | Isolated genomic polynucleotide fragments from the p15 region of chromosome 11 |
GB0104259D0 (en) * | 2001-02-21 | 2001-04-11 | Smithkline Beecham Biolog | Novel compounds |
GB0111974D0 (en) * | 2001-05-16 | 2001-07-04 | Glaxosmithkline Biolog Sa | Novel Compounds |
KR20050057047A (ko) | 2002-08-29 | 2005-06-16 | 제넨테크, 인크. | 아캐트-스큐트 유사-2 폴리펩티드 및 코딩 핵산 및 종양의진단 및 치료 방법 |
WO2008030559A2 (en) * | 2006-09-08 | 2008-03-13 | Corixa Corporation | Methods, compositions, and kits for the detection and monitoring of colon cancer |
GB0700284D0 (en) * | 2007-01-08 | 2007-02-14 | Glaxosmithkline Biolog Sa | Combination therapy |
-
2010
- 2010-05-25 EA EA201190274A patent/EA020617B1/ru not_active IP Right Cessation
- 2010-05-25 MX MX2011012623A patent/MX2011012623A/es active IP Right Grant
- 2010-05-25 SG SG2011086840A patent/SG176220A1/en unknown
- 2010-05-25 WO PCT/EP2010/057141 patent/WO2010136443A1/en active Application Filing
- 2010-05-25 US US13/322,282 patent/US8916514B2/en not_active Expired - Fee Related
- 2010-05-25 EP EP10721024A patent/EP2435469A1/en not_active Withdrawn
- 2010-05-25 AU AU2010252012A patent/AU2010252012A1/en not_active Abandoned
- 2010-05-25 KR KR1020117031060A patent/KR20120014054A/ko not_active Application Discontinuation
- 2010-05-25 CN CN201080033569.8A patent/CN102459324B/zh not_active Expired - Fee Related
- 2010-05-25 PE PE2011002023A patent/PE20120400A1/es not_active Application Discontinuation
- 2010-05-25 NZ NZ596501A patent/NZ596501A/xx not_active IP Right Cessation
- 2010-05-25 CA CA2763486A patent/CA2763486A1/en not_active Abandoned
- 2010-05-25 JP JP2012512340A patent/JP2012528106A/ja active Pending
- 2010-05-25 BR BRPI1012078A patent/BRPI1012078A2/pt not_active IP Right Cessation
- 2010-05-25 MA MA34476A patent/MA33409B1/fr unknown
-
2011
- 2011-11-11 DO DO2011000348A patent/DOP2011000348A/es unknown
- 2011-11-14 IL IL216351A patent/IL216351A0/en unknown
- 2011-11-25 CL CL2011002994A patent/CL2011002994A1/es unknown
- 2011-12-01 CO CO11165849A patent/CO6400229A2/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN102459324B (zh) | 2014-07-09 |
MX2011012623A (es) | 2011-12-14 |
AU2010252012A1 (en) | 2011-12-22 |
IL216351A0 (en) | 2012-01-31 |
CN102459324A (zh) | 2012-05-16 |
DOP2011000348A (es) | 2012-01-15 |
US20120070491A1 (en) | 2012-03-22 |
US8916514B2 (en) | 2014-12-23 |
EP2435469A1 (en) | 2012-04-04 |
NZ596501A (en) | 2013-11-29 |
CO6400229A2 (es) | 2012-03-15 |
JP2012528106A (ja) | 2012-11-12 |
SG176220A1 (en) | 2011-12-29 |
CL2011002994A1 (es) | 2012-07-20 |
KR20120014054A (ko) | 2012-02-15 |
MA33409B1 (fr) | 2012-07-03 |
WO2010136443A1 (en) | 2010-12-02 |
EA201190274A1 (ru) | 2012-06-29 |
PE20120400A1 (es) | 2012-05-04 |
CA2763486A1 (en) | 2010-12-02 |
EA020617B1 (ru) | 2014-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1012078A2 (pt) | construto de proteína, composição imunogênica, molécula de ácido nucleico , métodos de induzir uma resposta imune a casb7439 e de tratar um animal humano ou não-humano, e, uso de uma composição imunogênica | |
BRPI0716145A2 (pt) | formuaÇço de vacina, mÉtodo de adaptaÇço e propagaÇço do vÍrus chikungunya, mÉtodo de concentraÇço e purificaÇço de vÍrus, composiÇço potencialmente imunogÊnica, sequÊncia de nucleotÍdeo, contruto de dna recombinante, mÉtodo para produzir proteÍna recombinante, composiÇço farmacÊutica, mÉtodo in vitro ou in vivo e mÉtodo para elicitar resposta imune protetora | |
BRPI0906997A2 (pt) | Proteína, uso da proteína combinante ou fragmento da mesma, método para induzir uma resposta imune em um individuo, método para tratar um paceinte, construção de ácido nicleico, vetor de ezpressão o ucélula hospedeira, vacina, anticorpo, e, composição farmaceutica | |
BRPI0919531A2 (pt) | anticorpos contra il17 humana e usos dos mesmos | |
DK2358756T4 (da) | Humane antistoffer med høj affinitet til PCSK9 | |
EA201490393A1 (ru) | Соматотропный гормон пролонгированного действия и способы его получения | |
SG10201401995UA (en) | Stable high protein concentration formulations of human anti-tnf-alpha-antibodies | |
BRPI1012340A8 (pt) | proteínas de ligação específica e usos das mesmas | |
EP2023952A4 (en) | INDUCTION OF IMMUNE REACTIONS TO THE INFLUENZA AVIRUSES USING POLYPEPITD AND NUCLEIC ACID COMPOSITIONS | |
BR112016004472A2 (pt) | proteínas de ligação ao antígeno de gitr | |
CL2014000927A1 (es) | Proteinas naglu humana recombinante y usos de la misma | |
BRPI0920026A2 (pt) | método de tratamento de infecção pulmonar, composição farmacêutica e respectivos usos. | |
EA201270571A1 (ru) | Человеческие il-23-антигенсвязывающие белки | |
BR112012027055A8 (pt) | agente estabilizante para proteínas farmacêuticas. | |
AR090047A1 (es) | Dominio variable dual de inmunoglobulinas y sus usos | |
BRPI0820068A2 (pt) | Composição para nutrição humana e/ou animal, usos derivados e leveduras | |
BRPI0920246A2 (pt) | método de preparação de alfa-beta peptídios biologicamente ativos. | |
BR112012013868A2 (pt) | composição, proteína de fusão, polinucelotídeo, vetor ou constructo de gene, célula hospedeira , composição farmacêutica, método in vitro e uso de uma composição. | |
EA201170357A1 (ru) | Инженерные антитела к il-13: композиции, способы и применение | |
ATE492639T1 (de) | Multimer zur immunstimulation | |
MX2009004243A (es) | Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal. | |
SMT201600147B (it) | Metodi per migliorare l'espressione di proteine ricombinanti | |
WO2012083302A3 (en) | Compositions and methods for the treatment or prevention of human adenovirus-36 infection | |
EA201171232A1 (ru) | Способ переноса полипептидов в клетки | |
BR112012027531A2 (pt) | método de tratamento e/ou prevenção de progresso e/ou atraso de desenvolvimento de hepatite em um indivíduo, uso de uma molécula imunológica anti-cd3 e composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |